Literature DB >> 2417764

An ELISA-inhibition test using monoclonal antibody for the serology of leprosy.

P R Klatser, M Y De Wit, A H Kolk.   

Abstract

In this study a mouse monoclonal antibody (47-9) is described, which recognized an epitope on the 36 kD protein antigen of M. leprae. The monoclonal antibody showed specificity for M. leprae. An ELISA-inhibition test based on the competitive inhibition by antibodies from human test sera of the binding of the enzyme labelled monoclonal antibody to M. leprae was developed. Seropositivity was found in 100% of the multibacillary leprosy patients group and in 91% of the paucibacillary patients. Only 5% of the 223 control sera were positive. Because of the high seropositivity found in both multi- and paucibacillary patients, it is suggested that the epitope on the 36 kD antigen is immuno-dominant. Therefore the ELISA-inhibition test described herein might well be a suitable tool for diagnosis of leprosy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2417764      PMCID: PMC1577474     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

1.  Peroxidase-labeled antibody. A new method of conjugation.

Authors:  P K Nakane; A Kawaoi
Journal:  J Histochem Cytochem       Date:  1974-12       Impact factor: 2.479

2.  Antibody activity against Mycobacterium leprae antigen 7 in leprosy: studies on variation in antibody content throughout the spectrum and on the effect of DDS treatment and relapse in BT leprosy.

Authors:  L Yoder; B Naafs; M Harboe; G Bjune
Journal:  Lepr Rev       Date:  1979-06       Impact factor: 0.537

3.  Fluorescent leprosy antibody absorption (FLA-ABS) test for detecting subclinical infection with Mycobacterium leprae.

Authors:  M Abe; F Minagawa; Y Yoshino; T Ozawa; K Saikawa; T Saito
Journal:  Int J Lepr Other Mycobact Dis       Date:  1980-06

Review 4.  Mycobacterial antigens: a review of their isolation, chemistry, and immunological properties.

Authors:  T M Daniel; B W Janicki
Journal:  Microbiol Rev       Date:  1978-03

Review 5.  Immunoreactive substances of mycobacteria.

Authors:  M B Goren
Journal:  Am Rev Respir Dis       Date:  1982-03

6.  One-step purification of mouse monoclonal antibodies from ascitic fluid by DEAE Affi-Gel blue chromatography.

Authors:  C Bruck; D Portetelle; C Glineur; A Bollen
Journal:  J Immunol Methods       Date:  1982-09-30       Impact factor: 2.303

7.  Classification of leprosy according to immunity. A five-group system.

Authors:  D S Ridley; W H Jopling
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Jul-Sep

8.  Production and characterization of monoclonal antibodies to Mycobacterium tuberculosis, M. bovis (BCG) and M. leprae.

Authors:  A H Kolk; M L Ho; P R Klatser; T A Eggelte; S Kuijper; S de Jonge; J van Leeuwen
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

9.  A serological test for leprosy with a glycolipid specific for Mycobacterium leprae.

Authors:  D B Young; T M Buchanan
Journal:  Science       Date:  1983-09-09       Impact factor: 47.728

10.  Mycobacterium leprae specific antibodies detected by radioimmunoassay.

Authors:  M Harboe; O Closs; G Bjune; G Kronvall; N H Axelsen
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

View more
  9 in total

1.  Serological monitoring of previously treated lepromatous patients during a course of multiple immunotherapy treatments with heat-killed Mycobacterium leprae and BCG.

Authors:  J T Douglas; D S Hirsch; T T Fajardo; L S Guido; P R Klatser
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

2.  Enzyme-linked immunosorbent assay for distinguishing serological responses of lepromatous and tuberculoid leprosies to the 29/33-kilodalton doublet and 64-kilodalton antigens of Mycobacterium tuberculosis.

Authors:  P K Das; A Rambukkana; J G Baas; D G Groothuis; M Halperin
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

3.  Recognition of mycobacterial antigens by sera from patients with leprosy.

Authors:  F Vega-Lopez; N G Stoker; M F Locniskar; H M Dockrell; K A Grant; K P McAdam
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

4.  A major immunogenic 36,000-molecular-weight antigen from Mycobacterium leprae contains an immunoreactive region of proline-rich repeats.

Authors:  J E Thole; L F Stabel; M E Suykerbuyk; M Y De Wit; P R Klatser; A H Kolk; R A Hartskeerl
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

Review 5.  Leprosy.

Authors:  R C Hastings; T P Gillis; J L Krahenbuhl; S G Franzblau
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

6.  The presence in experimental animals of a colon specific Mr 40,000 protein(s) with relevance to ulcerative colitis.

Authors:  L Biancone; L S Wise; K M Das
Journal:  Gut       Date:  1991-05       Impact factor: 23.059

7.  Characterization of murine B-cell epitopes on the Mycobacterium leprae proline-rich antigen by use of synthetic peptides.

Authors:  P R Klatser; M Y De Wit; A H Kolk; R A Hartskeerl
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

8.  Serology and leprosy: immunoassays comparing immunoglobulin G antibody responses to 28- and 30-kilodalton proteins purified from Mycobacterium bovis BCG.

Authors:  M C Pessolani; J M Peralta; F D Rumjanek; H M Gomes; M A Marques; E C Almeida; M H Saad; E N Sarno
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

9.  Sequence and immunological characterization of a serine-rich antigen from Mycobacterium leprae.

Authors:  F Vega-López; L A Brooks; H M Dockrell; K A De Smet; J K Thompson; R Hussain; N G Stoker
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.